• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

New Science Ventures

edit

New Science Ventures (NSV) is a New York-based venture capital firm which invests in both early and late stage companies using novel scientific approaches to address significant unmet needs and create order of magnitude improvements in performance. NSV manages over $125 million and has invested in more than 20 companies located in the US, Europe, India and China in the life sciences and information technology sectors.

Recent Milestones

edit

• 
  New Science Ventures invested in Resolve Therapeutics. (11/1/12)
  Posted 11/1/12 at 9:07pm via finsmes.com
• 
  New Science Ventures invested in Juventas Therapeutics. (7/16/12)
  Posted 7/16/12 at 5:18pm via finsmes.com
• 
  New Science Ventures invested in Vaultive. (2/27/12)
  Posted 2/27/12 at 7:23pm via venturebeat.com
• 
  New Science Ventures invested in TigerText. (2/2/12)
  Posted 2/2/12 at 6:25pm via finsmes.com
• 
  New Science Ventures invested in Oxyrane UK. (11/17/11)
  Posted 11/17/11 at 8:25pm via finsmes.com
• 
  New Science Ventures invested in Resolve Therapeutics. (5/17/11)
  Posted 5/20/11 at 4:14am via finsmes.com
• 
  New Science Ventures invested in Bioscale. (6/14/10)
  Posted 6/14/10 at 8:02pm via onbiovc.com
• 
  New Science Ventures invested in Seahorse Bioscience. (3/8/10)
  Posted 3/10/10 at 5:12pm via onbiovc.com
• 
  New Science Ventures invested in BioVex. (3/30/09)
  Posted 3/30/09 at 2:17pm via fiercebiotech.com
• 
  New Science Ventures invested in Seahorse Bioscience. (3/9/09)
  Posted 6/20/09 at 12:18am via masshightech.com
• 
  New Science Ventures invested in Achronix Semiconductor. (10/15/08)
  Posted 4/11/09 at 7:25pm via achronix.com
• 
  New Science Ventures invested in TherOx. (2/1/08)
  Posted 5/22/09 at 2:28pm via vcastocks.com
• 
  New Science Ventures invested in FlowCardia. (8/30/07)
  Posted 7/16/09 at 5:25am via flowcardia.com
• 
  New Science Ventures invested in Ception Therapeutics. (1/29/07)
  Posted 3/10/10 at 8:03pm via ceptiontx.com
• 
  New Science Ventures invested in Achronix Semiconductor. (1/23/07)
  Posted 1/3/09 at 7:59am via prnewswire.com
• 
  New Science Ventures invested in Light Sciences Oncology. (12/14/05)
  Posted 7/1/10 at 3:25am via lsoncology.com

Investments

Videos

Sources

1. Resolve Therapeutics Raises $5.8M in Series B Financing (finsmes.com) [edit]
2. Juventas Therapeutics Closes $22.2M Series B Financing (finsmes.com) [edit]
3. Vaultive keeps your data safe in the cloud, raises $10M (venturebeat.com) [edit]
4. TigerText Completes $8.2m Second Funding (finsmes.com) [edit]
5. Oxyrane Raises $26.5M in Series D Funding (finsmes.com) [edit]
6. Resolve Therapeutics Raises $2M in Series A Financing (finsmes.com) [edit]
7. BioScale, Inc.: Series D $25M (onbiovc.com) [edit]
8. Seahorse Bioscience, Inc.: Series D $5M (onbiovc.com) [edit]
9. BioVex Raises $40 Million (fiercebiotech.com) [edit]
10. Seahorse Bioscience lands $6M, buys BioProcessors Corp (masshightech.com) [edit]
11. Achronix Completes First Close of $52 Million Series B Preferred Stock Financing (achronix.com) [edit]
12. TherOx raises $30,000,000 (vcastocks.com) [edit]
13. FlowCardia, Inc. Raises $30 Million In Series C Financing (flowcardia.com) [edit]
14. Ception Therapeutics Raises $63 Million in Series C Financing (ceptiontx.com) [edit]
15. Achronix Completes $25.4 Million Series A Preferred Stock Financing (prnewswire.com) [edit]
16. LIGHT SCIENCES ONCOLOGY COMPLETES SECOND CLOSING IN $67 MILLION FINANCING FOR LATE STAGE DEVELOPMENT OF LITXâ„¢ AND ANNOUNCES ADDITIONAL DIRECTORS (lsoncology.com) [edit]